IL134774A0 - A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST - Google Patents

A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Info

Publication number
IL134774A0
IL134774A0 IL13477498A IL13477498A IL134774A0 IL 134774 A0 IL134774 A0 IL 134774A0 IL 13477498 A IL13477498 A IL 13477498A IL 13477498 A IL13477498 A IL 13477498A IL 134774 A0 IL134774 A0 IL 134774A0
Authority
IL
Israel
Prior art keywords
selective
antagonist
combination
partial agonist
ht1b
Prior art date
Application number
IL13477498A
Other languages
English (en)
Original Assignee
Astrazeneca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca filed Critical Astrazeneca
Publication of IL134774A0 publication Critical patent/IL134774A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13477498A 1997-09-18 1998-09-09 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST IL134774A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703374A SE9703374D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001600 WO1999013876A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (1)

Publication Number Publication Date
IL134774A0 true IL134774A0 (en) 2001-04-30

Family

ID=20408294

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13477498A IL134774A0 (en) 1997-09-18 1998-09-09 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Country Status (29)

Country Link
US (1) US6159972A (cg-RX-API-DMAC10.html)
EP (1) EP1021183B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001516717A (cg-RX-API-DMAC10.html)
KR (1) KR20010024075A (cg-RX-API-DMAC10.html)
CN (1) CN1182847C (cg-RX-API-DMAC10.html)
AR (1) AR015447A1 (cg-RX-API-DMAC10.html)
AT (1) ATE261728T1 (cg-RX-API-DMAC10.html)
AU (1) AU752718B2 (cg-RX-API-DMAC10.html)
BR (1) BR9812234A (cg-RX-API-DMAC10.html)
CA (1) CA2302383A1 (cg-RX-API-DMAC10.html)
DE (1) DE69822490T2 (cg-RX-API-DMAC10.html)
DK (1) DK1021183T3 (cg-RX-API-DMAC10.html)
EE (1) EE04142B1 (cg-RX-API-DMAC10.html)
ES (1) ES2216307T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0100401A3 (cg-RX-API-DMAC10.html)
IL (1) IL134774A0 (cg-RX-API-DMAC10.html)
IS (1) IS5408A (cg-RX-API-DMAC10.html)
MY (1) MY116281A (cg-RX-API-DMAC10.html)
NO (1) NO20001398L (cg-RX-API-DMAC10.html)
NZ (1) NZ503174A (cg-RX-API-DMAC10.html)
PL (1) PL339370A1 (cg-RX-API-DMAC10.html)
PT (1) PT1021183E (cg-RX-API-DMAC10.html)
RU (1) RU2215528C2 (cg-RX-API-DMAC10.html)
SE (1) SE9703374D0 (cg-RX-API-DMAC10.html)
SK (1) SK2842000A3 (cg-RX-API-DMAC10.html)
TR (1) TR200000734T2 (cg-RX-API-DMAC10.html)
TW (1) TW568786B (cg-RX-API-DMAC10.html)
WO (1) WO1999013876A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA987810B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
USD969018S1 (en) 2021-06-28 2022-11-08 Koninklijke Asscher Diamant Maatschappij B.V. Rose pear diamond article

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA90673B (en) * 1989-02-02 1990-10-31 Yamanouchi Pharma Co Ltd Tetrahydrobenzimidazole derivatives
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
FI961247A0 (fi) * 1996-03-18 1996-03-18 Finnish Peroxides Ab Oy Foerfarande foer loesning av uppsvaellningsproblem i en avfalls vattenreningsanordning foer kontroll av traodartiga bakterier
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
SK2842000A3 (en) 2000-09-12
AR015447A1 (es) 2001-05-02
AU752718B2 (en) 2002-09-26
EP1021183B1 (en) 2004-03-17
TR200000734T2 (tr) 2000-11-21
MY116281A (en) 2003-12-31
NO20001398D0 (no) 2000-03-17
ZA987810B (en) 1999-02-18
PT1021183E (pt) 2004-07-30
CA2302383A1 (en) 1999-03-25
DK1021183T3 (da) 2004-07-05
CN1182847C (zh) 2005-01-05
RU2215528C2 (ru) 2003-11-10
WO1999013876A1 (en) 1999-03-25
DE69822490T2 (de) 2005-03-03
CN1279609A (zh) 2001-01-10
TW568786B (en) 2004-01-01
US6159972A (en) 2000-12-12
SE9703374D0 (sv) 1997-09-18
HUP0100401A2 (hu) 2002-01-28
ES2216307T3 (es) 2004-10-16
NO20001398L (no) 2000-04-04
HK1032740A1 (en) 2001-08-03
PL339370A1 (en) 2000-12-18
AU9192998A (en) 1999-04-05
NZ503174A (en) 2002-03-01
BR9812234A (pt) 2000-07-18
DE69822490D1 (de) 2004-04-22
IS5408A (is) 2000-03-15
EE04142B1 (et) 2003-10-15
JP2001516717A (ja) 2001-10-02
HUP0100401A3 (en) 2003-01-28
ATE261728T1 (de) 2004-04-15
EE200000143A (et) 2001-02-15
KR20010024075A (ko) 2001-03-26
EP1021183A1 (en) 2000-07-26

Similar Documents

Publication Publication Date Title
PL337781A1 (en) Antagonists and reverse antagonists of glucogene
IL139136A0 (en) Il-2 selective agonists and antagonists
SG85628A1 (en) Compound and its use
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
IL134776A0 (en) A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
ZA987804B (en) A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist
GB2346823B (en) Reamer and method of using the same
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
GB9820014D0 (en) Receptor antagonists and uses thereof
SG77642A1 (en) Point of use dilution tool and method
GB9704349D0 (en) Levobupivacaine and its use
ZA987810B (en) A combination of a selective 5HT1A antagonist and a selective h5-HT1B antagonist or partial agonist
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB9701374D0 (en) Purinergic agonists and antagonists
GB9617507D0 (en) Chemically modified elastomeres and blends thereof
SI1021183T1 (en) A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST
GB9704370D0 (en) Levobupivacaine and its use
GB2341533B (en) Jewellery and construction thereof
PL56866Y1 (en) Boring and facing head
GB9722023D0 (en) Levobupivacaine and its use
ZA989647B (en) Drilling and cementing through shallow waterflows
GB2321203B (en) Gaming-table and barrier therefor
GB9716815D0 (en) Hole cutting and forming apparatus
GB9810427D0 (en) Levobupivacaine and its use